Many public health responses and modeled scenarios for COVID-19 outbreaks caused by
SARS-CoV-2 assume that infection results in an immune response that protects individuals …

Rapid development of an efficacious vaccine against the viral pathogen severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of the coronavirus disease …

We still know very little about how the human immune system responds to SARS-CoV-2.
Here we construct a SARS-CoV-2 proteome microarray containing 18 out of the 28 predicted …

COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-
like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease …

Objectives: We aimed to evaluate the role of rapid serological tests in the management of
coronavirus disease 2019 (COVID-19) patients. Methods: This retrospective study enrolled …

The severe acute respiratory syndrome coronavirus (SARS-CoV) still carries the potential for
reemergence, therefore efforts are being made to create a vaccine as a prophylactic strategy …

More than a decade after the emergence of severe acute respiratory syndrome coronavirus
(SARS-CoV) in 2002/2003 the occurrence of a novel CoV termed Middle East respiratory …

C oronavirus disease 2019 (COVID-19) is an infectious dis-ease caused by severe acute
respiratory syndrome corona-virus 2 (SARS-CoV-2), which first appeared in Wuhan, China …

As a transmissible infectious disease, severe acute respiratory syndrome (SARS) was
successfully contained globally by instituting widespread quarantine measures. Although …

The 3C-like protease (3CLpro) of SARS-coronavirus mediates the proteolytic processing of
replicase polypeptides 1a and 1ab into functional proteins, becoming an important target for …